Article info
PDFOriginal research
Serotonin–norepinephrine reuptake inhibitors for the prevention of migraine and vestibular migraine: a systematic review and meta-analysis
- Correspondence to Dr Zhongxin Xu, Neurology, China-Japan Union Hospital of Jilin University, Changchun 130031, China; xuzhongxin9999{at}163.com
Citation
Serotonin–norepinephrine reuptake inhibitors for the prevention of migraine and vestibular migraine: a systematic review and meta-analysis
Publication history
- Received December 10, 2019
- Revision received March 1, 2020
- Accepted March 3, 2020
- First published March 23, 2020.
Online issue publication
April 22, 2020
Article Versions
- Previous version (22 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Society of Regional Anesthesia & Pain Medicine 2020. No commercial re-use. See rights and permissions. Published by BMJ.